Replimune Group Inc buy BMO Capital Markets
Start price
22.11.24
/
50%
€15.40
Target price
22.11.25
€17.31
Performance (%)
-69.09%
Price
15.08.25
€4.96
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Replimune Group Inc is performing very badly with a performance of -69.09%. This prediction currently runs until 22.11.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | 10.714% | 10.714% |
| iShares Core DAX® | 0.648% | 1.259% |
| iShares Nasdaq 100 | -0.034% | 2.797% |
| iShares Nikkei 225® | 2.445% | 9.854% |
| iShares S&P 500 | 0.492% | 2.570% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at BMO Capital Markets from $14.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€2.40
23.07.25
23.07.25
€1.70
23.07.26
23.07.26
98.33%
15.08.25
15.08.25
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-61.55%
15.08.25
15.08.25